Semaglutide

CAS: 910463-68-2

Ref. 3D-GLP-3875-PI

Produktinformation

• Name: Semaglutide
• Synonyme: Sermaglutide

Beschreibung

Semaglutide is a peptide that is used as a pharmacological agent. It is an analogue of glucagon-like peptide-1 (GLP-1) and has been shown to be effective in the treatment of type 2 diabetes, obesity, and other diseases. Semaglutide inhibits the enzyme DPP-4, which is responsible for the degradation of GLP-1. As a result, semaglutide increases levels of GLP-1, which stimulates insulin release from pancreatic beta cells. This drug also helps to reduce body weight through increased satiety and reduced food intake. The efficacy of semaglutide has been demonstrated in clinical trials with patients who have autoimmune diseases such as rheumatoid arthritis or Crohn’s disease. In addition, it has been found to be safe for use in patients with hepatic impairment or diabetic neuropathy.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 4,113.67 g/mol
• Formel: C₁₈₇H₂₉₁N₄₅O₅₉
• Reinheit: Min. 95%